Financial toxicity among patients with lung cancer in a publicly funded health care system.

Authors

null

Doreen Anuli Ezeife

Princess Margaret Cancer Centre, Toronto, ON, Canada

Doreen Anuli Ezeife, Joshua Morganstein, Sally C Lau, Lisa Le, David Cella, Penelope Ann Bradbury, Geoffrey Liu, Adrian G. Sacher, Frances A. Shepherd, Natasha B. Leighl

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session B: Projects Relating to Patient Experience; Projects Relating to Safety; Technology and Innovation in Quality of Care

Track

Projects Relating to Patient Experience,Projects Relating to Safety,Technology and Innovation in Quality of Care

Sub Track

Integrating Patient Experience Assessment and Patient Reported Outcomes into Practice

Citation

J Clin Oncol 36, 2018 (suppl 30; abstr 192)

DOI

10.1200/JCO.2018.36.30_suppl.192

Abstract #

192

Poster Bd #

D8

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Genitourinary Cancers Symposium

Comparison of financial toxicity among patients with non-metastatic versus metastatic renal cell carcinoma.

Comparison of financial toxicity among patients with non-metastatic versus metastatic renal cell carcinoma.

First Author: Michael D. Staehler

Poster

2023 ASCO Quality Care Symposium

National service is free, not cancer disease: Financial toxicity in a public universal coverage healthcare system.

National service is free, not cancer disease: Financial toxicity in a public universal coverage healthcare system.

First Author: Paola Russo

Poster

2023 ASCO Quality Care Symposium

The high cost of supplements, complementary therapy, and alternative medicine in patients with breast cancer.

The high cost of supplements, complementary therapy, and alternative medicine in patients with breast cancer.

First Author: Kaitlyn Lapen